Page 126 - PCC05

Our patients deserve trials
Investigate Collaborate Identify Improve
Bibliography/key references
1: Rodger MA, et al. Low‐molecular‐weight heparin and recurrent placenta‐mediated pregnancy complications: a meta‐analysis of individual patient data from randomised controlled trials. Lancet. 2016
Nov 26;388(10060):2629‐2641.
2: Skeith L, et al. A meta‐analysis of low‐molecular‐weight heparin to prevent pregnancy loss in women with
inherited thrombophilia. Blood. 2016 Mar 31;127(13):1650‐5.
3: de Jong PG, et al. ALIFE2 study: low‐molecular‐weight heparin for women with recurrent miscarriage and inherited thrombophilia‐‐study protocol for a randomized controlled trial.
Trials. 2015 May 7;16:208.
4: Akhtar MA, et al. Heparin for assisted reproduction: summary of a Cochrane review.
Fertil Steril. 2015 Jan;103(1):33‐4.
5: Schisterman EF, et al Preconception low‐dose aspirin and pregnancy outcomes: results from the EAGeR
randomised trial. Lancet. 2014 Jul 5;384(9937):29‐36
6: de Jong PG, et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or
without
inherited thrombophilia. Cochrane Database Syst Rev. 2014 Jul 4;(7):CD004734.
7: de Jong PG, Goddijn M, Middeldorp S. Antithrombotic therapy for pregnancy loss. Hum Reprod Update.
2013 Nov‐Dec;19(6):656‐73.
8: Akhtar MA, et al. Heparin for assisted reproduction. Cochrane Database Syst Rev. 2013 Aug 17;(8):CD009452.
9: Di Nisio M, et al. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta‐analysis. Blood. 2011 Sep 8;118(10):2670‐8.
Page 120 of 135
126